Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqing Wang

Showing results (371-380 of 399) with videos related to

Pageof 40
Sort By:
Science China. Life Sciences|March 3, 2021
Emergence and prevalence of naturally occurring lower virulent African swine fever viruses in domestic pigs in China in 2020Encheng Sun, Zhenjiang Zhang, Zilong Wang, et al.
Blood|October 8, 2024
Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesisWenqing Wang, Martin Arreola, Thomas Mathews, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancerTao Zhang, Wenji Xue, Daquan Wang, et al.
Cancer Biology & Therapy|May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world studyXiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
BMC Cancer|September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocolLin-Rui Gao, Xin Wang, Weiming Han, et al.
European Radiology|February 28, 2023
Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomasDongling Pei, Fangzhan Guan, Xuanke Hong, et al.
International Immunopharmacology|October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter studyNuo Yu, Cheng Chen, Xiaomin Wang, et al.
Oncotargets and Therapy|November 16, 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trialJun Liang, Mingyan E, Gang Wu, et al.
Cancer Biology & Therapy|October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective studyXin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort studyNuo Yu, Xiankai Chen, Jiao Li, et al.
Pageof 40

Showing results (371-380 of 399) with videos related to

Sort By:
Pageof 40
Science China. Life Sciences|March 3, 2021
Emergence and prevalence of naturally occurring lower virulent African swine fever viruses in domestic pigs in China in 2020Encheng Sun, Zhenjiang Zhang, Zilong Wang, et al.
Blood|October 8, 2024
Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesisWenqing Wang, Martin Arreola, Thomas Mathews, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 8, 2021
A validation study on the lung immune prognostic index for prognostic value in patients with locally advanced non-small cell lung cancerTao Zhang, Wenji Xue, Daquan Wang, et al.
Cancer Biology & Therapy|May 14, 2025
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world studyXiongtao Yang, Xiaomin Wang, Qin Xiao, et al.
BMC Cancer|September 23, 2020
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocolLin-Rui Gao, Xin Wang, Weiming Han, et al.
European Radiology|February 28, 2023
Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomasDongling Pei, Fangzhan Guan, Xuanke Hong, et al.
International Immunopharmacology|October 14, 2025
Impact of consolidation immunotherapy after definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: a real-world multicenter studyNuo Yu, Cheng Chen, Xiaomin Wang, et al.
Oncotargets and Therapy|November 16, 2013
Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trialJun Liang, Mingyan E, Gang Wu, et al.
Cancer Biology & Therapy|October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective studyXin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort studyNuo Yu, Xiankai Chen, Jiao Li, et al.
Pageof 40